Your cart
Your cart is empty
Continue shopping
Pharmacor
Ezetimibe + Rosuvastatin
Sale price
$12.29
-6%
Regular price
$12.95
Regular price
$12.29
Unit price
per
Low stock
In stock, ready to ship
Product Sold Out
More Information (API / 10mg x 30 Tabs + 10mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (API / 10mg x 30 Tabs + 20mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (API / 10mg x 30 Tabs + 40mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Sigma / 10mg x 30 Tabs + 10mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Sigma / 10mg x 30 Tabs + 20mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Sigma / 10mg x 30 Tabs + 40mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Symbion / 10mg x 30 Tabs + 10mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Symbion / 10mg x 30 Tabs + 20mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Symbion / 10mg x 30 Tabs + 40mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (CH2 / 10mg x 30 Tabs + 10mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (CH2 / 10mg x 30 Tabs + 20mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (CH2 / 10mg x 30 Tabs + 40mg x 30 Tabs)
Active Ingredients
rosuvastatin calcium 10.4mg Equivalent: rosuvastatin 10mg
Free-From
Gluten free
Gelatin free
Indicators
Primary Hypercholesterolaemia
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:
· not appropriately controlled with rosuvastatin or ezetimibe alone
· already treated with rosuvastatin and ezetimibe.
Homozygous Familial Hypercholesterolaemia (HoFH)
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Tablet Description
N/A
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
Connecting Care, Simplifying Supply.
At Pharmacor, we bridge the gap between healthcare providers and seamless supply solutions, ensuring care is always within reach.
Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
